The authors suggested that the composition of the gut microbiome may be one of the factors influencing the spontaneous anti-tumor immunity, as well as the enhanced therapeutic effects of drugs targeting the PD-1/PD-L1 axis [19]. Here, PDCD1 is linked to neoplasm.